000			05332nam a22004335i 4500
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
710	2		_aSpringerLink (Online service) _9106996
999			_c110444 _d110444 _x1
001			110444
003			ES-MaUEC
005			20230102113420.0
008			181112s2019 gw a o |||| 0|eng d
020			_a9783030017750
024	7		_a10.1007/978-3-030-01775-0 _2doi
040			_bspa _dES-MaUEC _cES-MaUEC
050		4	_aR857.N34 2019 EB
090		4	_aR856-857
245	0	0	_aNanotheranostics for Cancer Applications _cedited by Prakash Rai, Stephanie A. Morris.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2019.
300			_a1 recurso en línea (XIV, 480 páginas) _b89 ilustraciones, 83 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBioanalysis Advanced Materials Methods and Devices _x2364-1118 _v5
490	0		_aEngineering (Springer-11647)
505	0		_aAbout the Editors -- List of Contributors -- Part I Introduction to Cancer and Nanotechnology -- 1 Introduction -- 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics -- 3 Cancer Diagnostics and Therapeutics -- 4 Nanomedicine in Cancer -- 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications -- Part II Cancer Nanodiagnostics and Nanotherapeutics -- 6 In Vitro Cancer Diagnostics -- 7 Translational Nanodiagnostics for In Vivo Cancer Detection -- 8 Delivery of Cancer Nanotherapeutics -- 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations -- 10 Topical and Transdermal Nanomedicines for Cancer Therapy -- 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes -- Part III Regulatory Considerations for Nanomaterial Drug Products -- 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials -- 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials -- Part IV Cancer Nanotheranostics -- 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging -- 15 Image-Guided Drug Delivery -- 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring -- 17 Remotely-Triggered Nanotheranostics -- 18 Concluding Remarks and the Future of Nanotheranostics -- Index.
520	3		_aThis book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotely triggered drug delivery systems to limit cytotoxicity in the diseased area. This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the challenges and limitations of conventional cancer treatments, and presents an overview of the use of nanotechnology in treating cancer. These introductory chapters are followed by those exploring cancer diagnosis and a myriad of delivery methods for nanotherapeutics. The book also addresses multifunctional platforms, treatment monitoring, and regulatory considerations. As a whole, the book aims to briefly summarize the development and clinical potential of various nanotheranostics for cancer applications, and to delineate the challenges that must be overcome for successful clinical development and implementation of such cancer theranostics. Provides a comprehensive review of cancer nanotheranostics Represents the first book-length treatment of the topic Presents a full picture of the field, from basic research through clinical implementation Features evidence-based chapters with excellent illustrations and images to guide and assist the reader.
988			_aPrimersemestre_2019_Engineering
650		7	_2embne _aNanomedicina _9445593
650		7	_2embne _aNanotecnología _9158453
700	1		_aMorris, Stephanie A. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aRai, Prakash. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030017736
776	0	8	_iPrinted edition: _z9783030017743
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-01775-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b07/2019 _ejf _zSI